Navigation Links
Nerve damage may underlie widespread, unexplained chronic pain in children
Date:3/11/2013

Massachusetts General Hospital (MGH) investigators have described what may be a newly identified disease that appears to explain some cases of widespread chronic pain and other symptoms in children and young adults. Their report that will appear in the April issue of the journal Pediatrics, and has received early online release, finds that most of a group of young patients seen at the MGH for chronic, unexplained pain had test results indicating small-fiber polyneuropathy, a condition not previously reported in children. The MGH investigators call this new syndrome juvenile-onset small-fiber polyneuropathy or JOSeFINE.

"We've found the beginnings of a way to better evaluate young patients with otherwise unexplained widespread body pain," says Anne Louise Oaklander, MD, PhD, director of the Nerve Injury Unit in the MGH Department of Neurology and corresponding author of the Pediatrics paper. "By identifying the tests that are useful for diagnosing this condition, we hope to reduce the use of unnecessary, expensive, sometimes painful and potentially harmful testing that many of these children have undergone."

Small-fiber polyneuropathy (SFPN) involves widespread damage to the type of nerve fibers that carry pain signals from the skin and also control autonomic functions such as heart rate, blood pressure and sweating. Most commonly associated with diabetes, SFPN can be caused by other disorders in older adults or by exposure to toxic substances. Typical symptoms include chronic pain in several parts of the body, often beginning in the feet or lower legs, along with symptoms of autonomic dysfunction such as gastrointestinal problems, dizziness or fainting when standing, rapid heart rate, and changes in the appearance of skin. Specific diagnostic criteria have been established for SFPN, and accurate diagnosis can guide appropriate treatment choice.

Although polyneuropathy has been considered rare in children, occasional cases have be
'/>"/>

Contact: Mike Morrison
mdmorrison@partners.org
617-724-6425
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New technique may help severely damaged nerves regrow and restore function
2. New embryonic stem cell line will aid research on nerve condition
3. How does exercise affect nerve pain?
4. Exercise Appears to Ease Nerve-Damage Pain in Rat Study
5. Sleep Apnea May Be Linked to Nerve Damage in Diabetics
6. Nerve growth factors elevated in pancreatic cancer model
7. New candidate drug stops cancer cells, regenerates nerve cells
8. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
9. Taking the fate of stem cells in hand: RUB researchers generate immature nerve cells
10. JAAOS study highlights success of nerve transfer surgery
11. Long-term methadone treatment can affect nerve cells in brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... GoDaddy, IX Web Hosting and Bluehost are ... Server) hosting, which is the method of partitioning ... of which has the appearance and capabilities of ... recently compared many professional web hosting suppliers and ... VPS hosting suppliers in the global market. , ...
(Date:8/31/2014)... Mesa, Arizona (PRWEB) August 31, 2014 For ... ragweed is likely the culprit. Ragweed is the most common ... percent of Americans. , The most common symptoms of ragweed ... and throat, and sneezing. Ragweed allergy can also lead to ... ragweed allergies should consult an allergist about allergy immunotherapy - ...
(Date:8/31/2014)... 01, 2014 In order to celebrate the ... announced its latest designs and launched a big promotion. Now, ... , All the company’s new cars are made with ... for the global customers. As a matter of fact, it ... items. Those who are in need of cheap cars can ...
(Date:8/31/2014)... LabDoor.com tests the purity and label accuracy of ... website, “We buy products in the same fashion as ... sites. No manufacturer-supplied samples are permitted at LabDoor.” As ... a recent study was performed on twenty of the ... States for Vitamin D3 content, heavy metal contamination, and ...
(Date:8/31/2014)... 2014 In the wake of growing ... proposed legislation to require mandatory labeling of GMOs on ... purchasing decisions that affect their own health and the ... for stringent measures to eliminate GMOs from dietary supplements, ... Engagement” (I.C.E.) initiative with the objective of advancing the ...
Breaking Medicine News(10 mins):Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3
... , , ... Reportlinker.com announces that a new market research report is available ... Endoscopy Devices , , http://www.reportlinker.com/p0131252/Gastrointestinal-Endoscopy-Devices.html ... market for Gastrointestinal Endoscopy Devices in Millions of US$ analyzed by ...
... , Rx Bottles Filled with ... Fix Broken System Upon His Return to Washington ... Members of Congress have just returned to Washington D.C. after their ... to make reforming health care a top priority. With a giant ...
... Economic slump encourages more people ... Vancouver, ... more Canadians are making the decision to head back to school to re-train, instead of waiting ... Canada, has seen a dramatic spike in enrollments in 2009. Between July 2008 and July 2009, ...
... , , ... San Francisco biotechnology company developing oral-delivery vaccines, has been awarded a ... National Institute of Allergy and Infectious Disease (National Institutes of Health) ... H5N1 Avian influenza. , , "We thank ...
... ECCO 15 ESMO 34 will take place at ... D-14055 Berlin, Germany ( www.icc-berlin.de ) from Sunday 20 ... be more than 2,000 presentations and over 15,000 participants ... congress to date. The congress will discuss the ...
... , ATLANTA, Sept. 8 Renowned ... Coke, in collaboration with the American Dietetic Association (ADA) are providing ... Tastefully campaign will feature pop-up kitchens in midtown Manhattan and Boston, ... are all a part of living well. , , ...
Cached Medicine News:Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 2Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 3Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 4Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 5Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 6Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 7Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 8Health News:Fall 2009 Sees Spike in Enrollments at CDI College 2Health News:Vaxart Awarded NIH Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine 2Health News:Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress 2Health News:Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress 3Health News:Video: Eat Tastefully Campaign: Diet Coke, Renowned Chef, Pop-Up Kitchen Reveal Secrets to Great Taste, Living Well 2Health News:Video: Eat Tastefully Campaign: Diet Coke, Renowned Chef, Pop-Up Kitchen Reveal Secrets to Great Taste, Living Well 3Health News:Video: Eat Tastefully Campaign: Diet Coke, Renowned Chef, Pop-Up Kitchen Reveal Secrets to Great Taste, Living Well 4
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... Corporation , a neurodiagnostics medical device company based in ... Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, FRCSEd  was ... " Teo Forcht Dagi is an experienced leader with ... said Remis Bistras , President and CEO of Vittamed. ... entrepreneurial expertise to our Board." Dr. Dagi is ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... 5, 2011 Today Scios Inc. announced an agreement with ... misbranding of NATRECOR® (nesiritide), a prescription medication for patients with ... Scios Inc. entered a guilty plea to a single misdemeanor ... to pay an $85 million fine. Scios acknowledges ...
... Puma Biotechnology, Inc., a development stage biopharmaceutical company, ... the worldwide commercial rights to neratinib, a potent, ... through the epidermal growth factor receptors, ErbB1 (EGFR), ... being studied in the neoadjuvant, adjuvant and metastatic ...
Cached Medicine Technology:Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 2Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 3Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 4Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 5